Quality Of Life Data Excluded From Tarceva Label Due To Lack Of Validation
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Tarceva labeling excludes quality of life claims sought by Genentech/OSI in part because patient questionnaire components were not validated for stand-alone use, FDA review documents show